18 results
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
30 Nov 22
Cost Associated with Exit or Disposal Activities
4:32pm
. Bernstein, along with Chief Medical Officer, Marshelle Smith Warren, MD, will oversee the advancement of the eAPC program and clinical trial.
“The Board
S-1
EX-10.7
SQZB
SQZ Biotechnologies Co
9 Oct 20
IPO registration
4:59pm
be agreed upon by both Parties and are not subject to final decision by either Party);
oversee the JRDT and other JOTs;
discuss and approve … , and TCL Products must be agreed upon by both Parties and are not subject to final decision by SQZ);
review and oversee the execution of Collaboration
DRS/A
EX-10.7
SQZB
SQZ Biotechnologies Co
28 Aug 20
Draft registration statement (amended)
12:00am
be agreed upon by both Parties and are not subject to final decision by either Party);
oversee the JRDT and other JOTs;
discuss and approve … , and TCL Products must be agreed upon by both Parties and are not subject to final decision by SQZ);
review and oversee the execution of Collaboration
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
Authority” means any Government Entity having authority to monitor, oversee, impose, determine, or collect any Tax.
“Tax Return” means any return
DRS
p0548bi9 bh
21 Jul 20
Draft registration statement
12:00am
10-K
aedgjnqxw2672hbjf gk
18 Mar 21
Annual report
6:31am
DRS/A
1ngaahzy3pjvqzj
28 Aug 20
Draft registration statement (amended)
12:00am
424B4
ce166q0y01yt6vmr8jb
12 Feb 21
Prospectus supplement with pricing info
5:10pm
424B4
95b1wcyzuyev1hg
30 Oct 20
Prospectus supplement with pricing info
4:54pm
DRS/A
ep0brlwgpjydehhr0n77
25 Sep 20
Draft registration statement (amended)
12:00am
DRS
4r2yles6
1 Feb 21
Draft registration statement
12:00am
S-1
t0oos9gv9a
9 Oct 20
IPO registration
4:59pm
10-Q
qn13v
10 Dec 20
Quarterly report
4:46pm
PREM14A
lm2rzapx
12 Jan 24
Preliminary proxy related to merger
8:57am
DEFM14A
m2iq47 n3opao
23 Jan 24
Proxy related to merger
4:31pm
- Prev
- 1
- Next